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a b s t r a c t
The initial interplay between human cytomegalovirus (HCMV) and innate tissue response in the human
maternal–fetal interface, though crucial for determining the outcome of congenital HCMV infection, has
remained unknown. We studied the innate response to HCMV within the milieu of the human decidua,
the maternal aspect of the maternal–fetal interface, maintained ex vivo as an integral tissue. HCMV
infection triggered a rapid and robust decidual-tissue innate immune response predominated by
interferon (IFN)γ and IP-10 induction, dysregulating the decidual cytokine/chemokine environment in
a distinctive fashion. The decidual-tissue response was already elicited during viral-tissue contact, and
was not affected by neutralizing HCMV antibodies. Of note, IFNγ induction, reﬂecting immune-cell
activation, was distinctive to the maternal decidua, and was not observed in concomitantly-infected
placental (fetal) villi. Our studies in a clinically-relevant surrogate human model, provide a novel insight
into the ﬁrst-line decidual tissue response which could affect the outcome of congenital infection.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Human cytomegalovirus (HCMV) is the leading cause of con-
genital infection, affecting 0.5–2% of newborns. Congenital HCMV
disease develops in 25% of infected children, and is associated
with a wide spectrum of neurodevelopmental disabilities, intrau-
terine growth retardation (IUGR), and placental insufﬁciency
(Cannon, 2009; Ross and Boppana, 2005). Our current under-
standing of HCMV transmission and pathogenesis is limited by the
absence of animal models for congenital HCMV infection.
HCMV is transmitted from the mother to the fetus via the placenta
(Pereira et al., 2005), which, in addition to serving in viral transmission,
is actively injured by HCMV, contributing to the observed IUGR and
fetal disease (Pereira et al., 2005, 2014; Schleiss, 2006, 2007). The initial
steps of infection occur in the maternal decidua—representing the
maternal aspect of the chimeric maternal–fetal interface, where virus
originating from the mother ampliﬁes before further spread to the
adjacent placenta (Pereira and Maidji, 2008). The decidua is cohabited
by the uterine microvasculature, invasive interstitial cytotrophoblasts,
epithelial and stromal cells, as well as immune cells, with predomi-
nance of decidual NK cells (dNK) (Trundley et al., 2006).
Both immune and non-immune cells are known to be rapidly
activated upon HCMV infection, with induction of innate immune
response signaling cascades and inﬂammatory cytokines upon
viral sensing (Mocarski et al., 2007; Rossini et al., 2012). Thus far,
HCMV-induced innate responses have been studied mainly in
single-cell-type cultures, such as ﬁbroblasts and myeloid-lineage
cells (Chaudhuri et al., 2009; Compton et al., 2003; Juckem et al.,
2008; Mezger et al., 2009; Varani et al., 2007; Yurochko and
Huang, 1999). In the context of congenital HCMV infection,
adaptive immunity has clearly been more extensively evaluated
than innate immune responses (Schleiss, 2013). While the poten-
tial contribution of innate responses to antiviral defense as well as
to adverse tissue damage is increasingly recognized for diverse
viral infections (Iwasaki and Medzhitov, 2013; Kobasa et al., 2007;
Monroe et al., 2014; Rossini et al., 2012), their role in congenital
HCMV transmission and outcome has remained elusive, in the
absence of clinically-relevant model systems.
We have recently established a novel ex vivo model of HCMV
infection in human decidual tissues maintained as multi-cell-type
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organ cultures, and demonstrated the spread and the broad target-
cell range of the virus in the decidua (Weisblum et al., 2011). These
ﬁndings reﬂected the ability of the ex vivo infected decidual culture to
address the complexity of HCMV interactions with its diverse cellular
targets within the natural tissue milieu. In the present work, we have
employed the decidual culture model to study the decidual-tissue
innate response to HCMV infection. Using both laboratory-adapted
and clinically-pathogenic strains from congenital HCMV cases, we
have identiﬁed a distinctive decidual tissue innate immune response
pattern to HCMV infection.
Results
HCMV induces a robust decidual-tissue innate immune response
The decidual tissue is composed of multiple cell types in addition
to the extracellular milieu. Its innate response to HCMV, as an integral
tissue, is therefore likely to recapitulate the in vivo responses more
accurately than individual cell types grown in culture. To evaluate the
effect of HCMV infection on decidual cytokines/chemokines proﬁle,
we ﬁrst analyzed the levels of representative immune and angiogenic
cytokines/chemokines in cleared supernatants of HCMV-infected and
mock-infected decidual organ cultures at 7 days post infection (dpi),
using an ELISA immune assay (Table 1). To account for the tissue-to-
tissue variability, mean values were calculated for 5 independent
tissues obtained from different individuals. While the majority of the
analyzed cytokines were not altered by more than 2-fold following
infection, HCMV substantially induced decidual secretion of interferon
(IFN)γ (35 fold; p¼0.03), the T-cell attracting chemokine Interferon
inducible Protein-10 (IP-10; 4.7 fold; p¼0.008) and IFNβ (5.5 fold, not
statistically signiﬁcant). Similar induction of IFNγ and IP-10 were
observed at 24 h post infection (hpi; data not shown).
In further comparative analyses, we quantiﬁed the effect of
HCMV infection on decidual-tissue cytokines/chemokines mRNA
levels, using quantitative real-time RT-PCR. In accordance with the
secretion pattern, HCMV infection signiﬁcantly induced decidual
transcription of IFNγ and IP-10 as well as the interferon stimulated
gene MxA (Fig. 1A) in all the decidual tissues examined (4100),
despite the expected tissue-to-tissue variations. Induction was
similarly observed in tissues obtained from HCMV seropositive
(64% of the total) and HCMV seronegative (36%) donors. No
signiﬁcant alterations of IL-10 and VEGF mRNA levels were
observed (Fig. 1A).
To evaluate whether HCMV infection affects the tissue distribution
of IP-10, histological sections of infected and mock-infected decidua
were examined at 8 dpi (Fig. 1B). Immunohistochemical analysis
revealed that in addition to the upregulation of IP-10 expression,
HCMV infection drastically altered the distribution of IP-10 from
distinct focal expression (in mock-infected tissues) to widely-
distributed expression (in infected decidual tissues), detected in both
infected and uninfected cells throughout the decidua.
Decidual tissue innate response kinetics
We quantiﬁed the HCMV immediate early (IE)-1 gene and the
tissue cytokine mRNA levels over time. MxA, IFNγ, and IP-10
expression was already induced at 6 hpi, with continued increase
reﬂecting the viral spread (Fig. 2).
Together, these ﬁndings reveal the rapid immune activation
with creation of a proinﬂammatory environment in the decidual-
tissue upon HCMV infection.
Induction of decidual innate response by viral particles
When decidual tissues were infected with 10-fold escalating doses
of puriﬁed viral particles, a dose-proportional increase in IFNγ and IP-
10 induction was demonstrated (Fig. 3A). The rapid and dose-
dependent innate response of the decidual-tissue suggested that it
was triggered by the viral particles immediately upon infection. We
have therefore compared the induction of IFNγ and IP-10 expression
following exposure to infectious versus UV-inactivated virions.
Whereas no viral gene expression was detected following decidual
exposure to UV-inactivated virions (Fig. 3B), a similar induction of
IFNγ and IP-10 expression was observed, compared to infectious
virions (Fig. 3B). This ﬁnding indicated that the induced decidual
response does not require viral gene expression, but is rather
triggered by virion structural component/s.
Furthermore, a similar innate response pattern was observed
after infection with HCMV laboratory-derived strain AD169, the
clinically-derived strain TB40/E, and the low-passage clinical
isolates CI851, CI893, and CI943 (Fig. 3C), suggesting the potential
triggering by conserved viral structural protein/s.
HCMV glycoprotein B (gB) is a major viral-envelope glycoprotein,
implicated in the induction of cellular innate responses (Compton
et al., 2003; Rossini et al., 2012). Incubation of decidual cultures with
puriﬁed soluble gB resulted in a signiﬁcant induction of IFNγ and
IP-10 expression (Fig. 3D). This signiﬁcant induction was similarly
observed for each of 2 independent lots of mammalian cell-expressed
gB (results are shown for one lot) and an unrelated preparation of
baculovirus-insect-cell expressed and puriﬁed soluble gB, whereas no
induction was observed following parallel incubation of decidual
cultures with control glycosylated bovine serum albumin (BSA;
Fig. 3D). These results identify the contribution of HCMV gB to
activation of the decidual-tissue innate response.
Decidual-tissue innate response is already induced upon virus-cell
contact
Neutralizing HCMV hyperimmune globulins (HIG) do not inhibit the
decidual-tissue innate response
Clinical studies have suggested that treatment with HCMV HIG
can reduce maternal–fetal transmission and congenital disease,
although more recent controlled studies have not conﬁrmed the
effect on transmission (Nigro et al., 2005; Revello et al., 2014). We
have shown that HCMV HIG efﬁciently neutralize HCMV infection
of decidual organ culture (Weisblum et al., 2011). Here we sought
to examine whether blocking the ﬁrst steps of the virus replication
cycle by neutralizing antibodies could also inhibit the viral-
induced decidual innate response. Interestingly, despite the com-
plete inhibition of infection (as revealed by the abrogated viral IE-
1 expression), preincubation of puriﬁed viral particles with HCMV
HIG had no effect on the decidual innate response to HCMV
(Fig. 4A). As HCMV neutralizing antibodies have been shown to
block the viral fusion and internalization step, but do not interfere
with the initial virus binding at the cell surface (Compton, 2004;
Potzsch et al., 2011)—our ﬁnding indicates that the decidual-tissue
innate response is already activated upon the earliest stages of
infection involving viral glycoprotein binding to cell surface
receptor/s.
Heparin partially abolishes the decidual-tissue innate response. Initial
viral attachment involves binding of viral envelope glycoproteins to
cell surface heparan sulfate proteoglycans (HSPG), a process known to
be inhibited by heparin. To investigate the contribution of virion—
HSPG binding to the decidual-tissue innate response, puriﬁed HCMV
was incubated with heparin prior to decidual infection. Heparin
completely inhibited HCMV decidual infection, which resulted in a
signiﬁcant (po0.05) albeit partial abolishment of IP-10 and IFNγ
induction (Fig. 4B). No non-speciﬁc cytokine effects of heparin on the
examined parameters were observed (Fig. 4B). This differential effect,
identiﬁes the relative contribution of viral recognition by cell surface
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Fig. 1. Effect of HCMV infection on decidual cytokines/chemokines expression. (A) HCMV (5104 PFU/well, strain TB40/E)- and mock-infected decidual tissue RNA was
extracted at 7 dpi and the indicated mRNA levels were analyzed by quantitative RT-PCR and normalized by the house keeping gene β actin. Results are shown for
3 independent tissues. UD; undetectable levels. (B) Decidual cultures were infected with β galactosidase-encoding HCMV strain RC256 (5104 PFU/well). Mock and infected
cultures were subjected to immunohistochemistry analysis for IP-10 antigen (red staining) at 8 dpi. HCMV infected cells were detected by X-gal staining (blue). The insert
shows a cell co-stained for IP-10 and X-gal. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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HSPG, yet suggests the involvement of additional viral cell-receptor
interactions in activation of the decidual-tissue innate response.
HCMV-induced innate response pattern is distinctive to the decidual
tissue
The maternal-decidua constitutes a unique site, containing
both immune and non-immune cells. To determine whether the
observed innate response pattern is speciﬁc to the decidual tissue,
we compared the response between the decidual tissues and the
adjacent placental chorionic villi (representing the fetal aspect of
the maternal–fetal interface). Interestingly, induction of IFNγ was
unique to the decidual-tissue, and was not observed in
concomitantly-infected villi from the same donors. In contrast,
MxA and IP-10 expression was induced in both tissues (Fig. 5).
Since IFNγ is known to be produced exclusively by cells of the
immune system (Rossini et al., 2012), The speciﬁc predominance of
IFNγ response in the decidual tissue clearly indicates active and
distinctive decidual immune-cell response to HCMV infection.
Discussion
Whereas the role of adaptive immunity in the context of con-
genital HCMV infection has been extensively evaluated, the initial
interplay between the invading virus and the innate tissue response
in the human maternal–fetal interface, though crucial for determining
the outcome of congenital HCMV infection, has remained unknown.
Our studies of HCMV infection in structurally-integral human decid-
ual tissues are the ﬁrst to reveal the earliest innate response to the
virus within the whole-tissue decidual milieu.
We demonstrated that HCMV infection induced a robust tissue
innate immune response, signiﬁcantly altering the decidual cytokine
and chemokine environment. A consistent innate response patternwas
Fig. 2. Decidual tissue response kinetics. Decidual cultures were infected with
HCMV strain TB40/E (5104 PFU/well). At the indicated times post infection, RNA
was extracted and the indicated mRNA levels were analyzed by quantitative RT-PCR
and normalized by the house keeping gene β actin. Results are shown for HCMV
infected decidual tissues. The data shown are representative of at least three
independent experiments, each tested in 5 replicates.
Fig. 3. Induction of the decidual tissue response by structural virion compo-
nent/s. Decidual cultures were exposed to 10-fold escalating doses of puriﬁed virus
ranging from 5102 to 5105 PFU/ml (5101 to 5104 PFU/well) as indicated
(A), infectious or UV-inactivated HCMV strain TB40/E (5104 PFU/well) (B), HCMV
strains TB40/E, AD169 and the low-passage clinical isolate CI851 (5104 PFU/well)
(C), or two unrelated preparations of puriﬁed recombinant HCMV glycoprotein B
(gB#1—expressed in human cells, gB#2—baculovirus-insect cells expressed;
200 ng/well) and control glycosylated bovine serum albumin (BSA; 200 ng/well)
(D). Decidual tissue RNA was extracted at 12 h post infection or incubation, and the
indicated mRNA levels were analyzed by quantitative RT-PCR and normalized by
the house keeping gene β actin. The data shown are representative of at least three
independent experiments, each tested in 5 replicates. UD; undetectable levels.
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noted in all the decidual tissues examined (over 100), regardless of the
HCMV serological status of the donors. This observation (in tissues
from seronegative donors) indicates a primary innate immune
response to infection that is independent of adaptive immunity. While
we found predominant induction of IFNγ and IP-10 expression,
reﬂecting immune activationwithin the decidua upon HCMV infection,
no signiﬁcant induction of the anti-inﬂammatory cytokines IL-10 and
IL-4 was observed (Table 1, Fig. 1). Of note, a genome-wide transcrip-
tome analysis of infected andmock-infected decidual tissues conﬁrmed
this pattern, with the highest induction found in IFNγ, CXCL11, and
CXCL10 (IP-10) expression (data not shown). This overall shift towards
a proinﬂammatory environment is in agreement with the proinﬂam-
matory bias exerted by HCMV in clinical settings of systemic infection,
and with the increased expression of Th1 cytokines, as reported in
infected cells and term-placental cultures and in amniotic ﬂuid speci-
mens from a few cases of congenital HCMV (Chaudhuri et al., 2009;
Hamilton et al., 2012; Mocarski et al., 2007; Rossini et al., 2012; Scott
et al., 2012). However, the decidual innate response followed a
distinctive pattern: unlike the ﬁndings in cultured cells, we did not
observe a predominant induction of type I interferons and an increase
of proinﬂammatory cytokines TNFα, IL-6, and IL-1β. Furthermore, the
decidual-tissue response pattern differed from the reported response of
isolated dNK, characterized by IL-6 induction, with no upregulation of
IFNγ, and rather downregulation of IP-10 (Siewiera et al., 2013). These
discordances could result from, ﬁrst, the difference between studies in
cultured single-type cells versus our study in a multi-cell-type solid
tissue, containing a variety of maternal and fetal cells (which more
closely mirrors infection in vivo; (Weisblum et al., 2014) and, second,
the particular composition of the decidua, cohabited by both immune
and non-immune cell types, and geared for protection and immune-
tolerance of the developing fetus.
Interestingly, and further attesting to the speciﬁc nature of the
decidual-tissue response, we found that the HCMV-induced
expression of IFNγ was exclusive to the maternal-decidua, and
was not observed in concomitantly-infected placental villi,
whereas MxA and IP-10 were similarly-induced in both tissues
(Fig. 5). The predominance of IFNγ—known to be produced
exclusively by cells of the immune system-clearly indicates active
ex vivo decidual immune-cell response to infection. In this regard,
decidual immune cells are predominated by a unique population
of dNK, accounting for 70% of the decidual lymphocytes (which
are absent in placental villi), and we and others have shown that
HCMV infection modulates dNK and NK responses (Arnon et al.,
2005; Le Bouteiller, 2013; Markel et al., 2002; Stern-Ginossar et al.,
2007). Indeed, we could detect a multitude of CD56bright dNK cells
co-mingling with HCMV infected cells in the decidual organ
culture (data not shown). Yet we cannot exclude the additional
contribution of adaptive ex vivo lymphocyte response in tissues
obtained from seropositive women. Further studies directly focus-
ing on the responding cell populations within the infected
decidual tissue are currently underway in our laboratory.
The decidual tissue innate immune response was already elicited
upon initial interaction with virion particles, as revealed by the rapid
kinetics (Fig. 2), the viral particle-dose-dependent manner, and the
similar induction of IFNγ, IP10 and MxA by infectious and UV-
inactivated virions (Fig. 3). The triggering role of a conserved surface
glycoprotein was further suggested by the ﬁnding that low-passage
clinical strains derived from congenital HCMV cases and laboratory-
adapted strains elicited similar decidual response (Fig. 3). In accordance
with previous studies in cell cultures (Compton et al., 2003; Rossini
et al., 2012), we directly demonstrated the induction of decidual-tissue
innate response by soluble viral gB (Fig. 3D). Of note, the tissue
response was only partially abolished by heparin (Fig. 4) - known to
inhibit binding of viral envelope glycoproteins to cell surface HSPG
(Compton et al., 1993). This suggested the potential contribution of
additional viral interactions with pattern recognition receptors, as
indeed shown in infected cell cultures for Toll-like receptor 2, CD14,
and surface integrins (Compton et al., 2003; Rossini et al., 2012). We
further showed that neutralizing HCMV HIG demonstrated a differ-
ential effect, completely inhibiting viral infection, yet leaving the
decidual-tissue response unaffected (Fig. 4). As neutralizing antibodies
have been shown to block viral-cell membrane fusionwithout affecting
Fig. 4. Effect of early viral inhibitors on the decidual tissue response to HCMV.
HCMV strain TB40/E (puriﬁed virus; 5105 PFU/ml¼5104 PFU/well) was incu-
bated with HCMV hyperimmune globulins (HIG; Megalotect 10 mg/ml) (A), or
heparin (HEP; 500 IU/ml) (B), for 1 h prior to infection. Decidual tissue RNA was
extracted at 12 hpi, and the indicated mRNA levels were analyzed by quantitative
RT-PCR and normalized by the house keeping gene β actin. The data shown are
representative of at least three independent experiments, each tested in 5 repli-
cates. UD; undetectable levels.
Fig. 5. Comparison of decidual and placental response to HCMV infection.
Decidual and placental chorionic villi cultures from the same donors were
concomitantly infected with HCMV strain TB40/E (5104 PFU/well). Decidual
and placental tissue RNA was extracted at 7 dpi, and the indicated mRNA levels
were analyzed by quantitative RT-PCR and normalized by the house keeping gene β
actin. The data shown are representative of at least three independent experiments,
each tested in 5 replicates. UD; undetectable levels. DEC; decidua, PLA; placenta.
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the preceding events of viral glycoproteins’ binding to cell surface
receptors (Compton, 2004; Potzsch et al., 2011), their disparate effect
corroborates the immediate activation of decidual innate immune
response by an initial viral glycoprotein binding step.
In view of the known key-roles of IFNγ and IP-10 in both innate
and adaptive immune responses, and their increasingly recognized
non-immune functions during healthy placentation (Hanna et al.,
2006; Iwasaki and Medzhitov, 2013; Murphy et al., 2009; Sadler
and Williams, 2008), it is conceivable that their local induction by
HCMV as identiﬁed herein, could have consequences on virus
transmission and placental development. Furthermore, an over-
exuberant response has been shown to mediate poorer disease
outcomes following diverse viral infections (Gross et al., 2011;
Iwasaki and Medzhitov, 2013; Kobasa et al., 2007; Monroe et al.,
2014), and has been recently implicated in the brain pathology of
neonatal murine CMV infection (Kosmac et al., 2013). The pro-
found dysregulation of the decidual chemokine homeostasis
following HCMV infection, as demonstrated by the signiﬁcant
induction of IP-10 and CXCL11 along with the modiﬁed tissue
distribution of IP-10 (Fig. 1), is expected to lead to increased
lymphocyte access to the maternal–fetal interface, hence imped-
ing the specialized immune-privileged environment in the
decidua. In this regard, our data could provide a mechanistic basis
for the characteristic pathological features of naturally-infected
placenta, namely, increased lymphocyte inﬁltration (forming the
characteristic villitis and deciduitis), necrosis, edema, and ﬁbrosis
(Gabrielli et al., 2012; Pereira et al., 2014). The predominance of
these ﬁndings in vivo in cases of congenital HCMV disease and
IUGR, argues for the important role of the viral-induced innate
tissue response in the pathogenesis of congenital infection.
Application of the decidual organ culture system for the study
of innate immune responses to HCMV has obvious limitations in
terms of analyzing the distinct molecular mechanisms underlining
the observed ﬁndings at the cellular level. Yet, the complex
structure of the decidual-tissue, which is composed of a multitude
of cell types and extracellular matrix components, better reﬂects
the in vivo clinical setting of HCMV infection, spread, and patho-
genesis within the maternal–fetal interface.
Our studies in a clinically-relevant surrogate human model,
provide a novel insight into the ﬁrst-line decidual tissue response
which could affect the outcome of congenital infection.
Materials and methods
Cells and viruses
Primary HFF were used for HCMV propagation (Wolf et al.,
2001, 1995). The HCMV strains used were AD169 (obtained from
the American Type Culture Collection), TB40/E expressing IE2-
fused EYFP (generously provided by M. Winkler, Germany) (Dal
Pozzo et al., 2008), and Towne-RC-256, containing the LacZ gene
(Spaete and Mocarski, 1987). In addition, we used the low-passage
clinical isolates CI851, CI893, and CI943, recovered at the Hadassah
Clinical Virology Laboratory from urines of congenitally-infected
newborns, and propagated in HFF for 3–5 passages. Viral UV
inactivation was performed with UV Stratalinker 2400 (Strata-
Gene) at 0.99 J. For viral puriﬁcation, ultracentrifugation (at
24,000 rpm) of cleared virus supernatants through a 10% sucrose
cushion was performed.
Preparation and infection of decidual and placental chorionic villi
organ cultures
Decidual organ cultures were prepared and infected as pre-
viously described (Weisblum et al., 2011). Similar procedures were
followed for preparation and infection of cultures derived from
adjacent placental chorionic villi.
The study was approved by the Hadassah Medical Center Institu-
tional Review Board (0138-08-HMO), and performed according to the
Declaration of Helsinki, Good Clinical Practice guidelines, and the
Human-Experimentation Guidelines of the Israeli Ministry of Health.
All participants signed written informed consent. In brief, ﬁrst-
trimester decidual tissues were cut by a microtome into thin slices
and incubated in decidual medium: DMEM with 25% Ham’s F12, 10%
fetal bovine serum, 2 mM glutamine, 100 IU/ml penicillin, 100 μg/ml
streptomycin, and 0.25 μg/ml amphotericin B (Biological industries),
in 37 1C, 5% CO2. Tissue viability was monitored as described
previously (Weisblum et al., 2011). For infection of decidual organ
cultures, the tissues were placed in 48-well plates and inoculated
with the indicated virus (5104 plaque forming units (PFU)/well
unless otherwise stated) for 12 h to allow effective viral adsorption.
Following viral adsorption, the cultures were washed extensively and
further incubated for the duration of the experiment with replace-
ment of the culture medium every 2–3 days.
Speciﬁc treatments
HCMV glycoprotein B (gB): decidual organ cultures were
incubated with 2 mg/ml soluble recombinant HCMV gB (Sino
biological Inc. and an additional unrelated baculovirus-insect cell
expressed and puriﬁed soluble gB, kindly provided by Yarden
Opatowsky, Bar-Ilan University), or control glycosylated bovine
serum albumin (BSA; Promega).
HCMV hyperimmune globulins (HIG) and heparin: HCMV
(5105 PFU/ml of puriﬁed virus) was pre-incubated with 10 mg/
ml HCMV HIG (Megalotect; Biotest) or 500 IU/ml heparin (Sigma-
Aldrich) for 1 h, prior to inoculation.
At 12 hpi, cultures were washed extensively and stored at
70 1C until RNA puriﬁcation.
Multiplex-ELISA immunoassay
Supernatants of mock- and HCMV-infected decidual cultures
(and placental chorionic villi cultures, when indicated) were
collected at 1 d and 7 d post infection (dpi) and stored at
70 1C. Samples thawed on ice were subjected to analysis by a
Table 1
Effect of HCMV infection on decidual cytokines/chemokines secretion.
Cytokine/chemokine Infected/Mock 7SEMa p Valueb,c
IFNγ 35.2718.3 0.033 n
IFNβ 5.573.8 0.259
IP-10 4.771.2 0.008 n
PDGF-BB 4.5 72.2 0.058
IL-10 2.670.8 0.052
bFGF 2.671.6 0.33
IL-4 1.970.7 0.108
IL-1α 1.170.3 0.649
TNFα 1.170.2 0.444
IL-6 0.970.1 0.84
IL-1β 0.970.2 0.55
ANG-2 0.870.2 0.302
VEGF 0.870.1 0.029 n
IL-15 0.770.1 0.024 n
IL-2 0.670.1 0.002 n
a Ratios between the levels of cytokines secreted from HCMV-infected and
mock-infected decidual cultures at 7 dpi were tested in 4 replicates for 5 indepen-
dent tissues obtained from different individuals. Results are shown as mean7-
standard error (SEM).
b All data (mean7SEM) were analyzed using unpaired, two-tailed t tests for
comparisons between two groups.
c Signiﬁcant differences are highlighted in bold and marked with an asterisk
(n).
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microplate-based immunoassay, measuring 16 analytes (Table 1)
in a single well (Q-plexTM array, Quansys Biosciences).
Histological and immunohistochemistry analysis
Mock- and HCMV-(strain RC-256) infected decidual tissues
were stained for β-galactosidase (Braun et al., 2006), formalde-
hyde-ﬁxed, parafﬁn-embedded, and sectioned (5 μm-thickness).
Sections were placed in 0.01 M citrate buffer and warmed in a
pressure-cooker to 110 1C for 5 min, cooled to room temperature,
incubated with IP-10 mouse monoclonal antibodies (1:20 dilution;
R&D systems), washed, and incubated with HRP-conjugated goat
anti-mouse antibodies (Biocare Medical).
RNA puriﬁcation and quantiﬁcation
Infected decidual tissues and HFF were washed and stored at
70 1C until assayed. RNA was extracted (NucleoSpin RNA isola-
tion kit; Macherey-Nagel), and subjected to reverse-transcription
(GoScriptTM; Promega), followed by quantitative real-time PCR
(7900HT; Applied Biosystems). Primers and probes are listed in
Table S1.
Statistical analysis
All data (mean7SEM) were analyzed using unpaired, two-
tailed t tests for comparisons between two groups; p values of
o0.05 were considered signiﬁcant.
Acknowledgments
This work was supported by grants from the Israel Science
Foundation (grant number 275/13), the European Union Seventh
Framework Programme 562 FP7/2012-2016 (grant agreement
number 316655), and the Israeli Ministry of Health.
We thank Dr. Yarden Opatowsky for providing the puriﬁed
recombinant gB, and Dudi Shneor, Haya Falk, Tzlil Baruch and
Raphael Lieber for technical assistance.
Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.virol.2015.06.023.
References
Arnon, T.I., Achdout, H., Levi, O., Markel, G., Saleh, N., Katz, G., Gazit, R., Gonen-
Gross, T., Hanna, J., Nahari, E., Porgador, A., Honigman, A., Plachter, B.,
Mevorach, D., Wolf, D.G., Mandelboim, O., 2005. Inhibition of the NKp30
activating receptor by pp65 of human cytomegalovirus. Nat. Immunol. 6,
515–523.
Braun, E., Zimmerman, T., Hur, T.B., Reinhartz, E., Fellig, Y., Panet, A., Steiner, I., 2006.
Neurotropism of herpes simplex virus type 1 in brain organ cultures. J. Gen.
Virol. 87, 2827–2837.
Cannon, M.J., 2009. Congenital cytomegalovirus (CMV) epidemiology and aware-
ness The Ofﬁcial Publication of the Pan American Society for Clinical Virology.
J. Clin. Virol. 46 (Suppl. 4), S6–10.
Chaudhuri, S., Lowen, B., Chan, G., Davey, A., Riddell, M., Guilbert, L.J., 2009. Human
cytomegalovirus interacts with toll-like receptor 2 and CD14 on syncytiotro-
phoblasts to stimulate expression of TNFalpha mRNA and apoptosis. Placenta
30, 994–1001.
Compton, T., 2004. Receptors and immune sensors: the complex entry path of
human cytomegalovirus. Trends Cell Biol. 14, 5–8.
Compton, T., Kurt-Jones, E.A., Boehme, K.W., Belko, J., Latz, E., Golenbock, D.T.,
Finberg, R.W., 2003. Human cytomegalovirus activates inﬂammatory cytokine
responses via CD14 and Toll-like receptor 2. J. Virol. 77, 4588–4596.
Compton, T., Nowlin, D.M., Cooper, N.R., 1993. Initiation of human cytomegalovirus
infection requires initial interaction with cell surface heparan sulfate. Virology
193, 834–841.
Dal Pozzo, F., Andrei, G., Daelemans, D., Winkler, M., Piette, J., De Clercq, E., Snoeck,
R., 2008. Fluorescence-based antiviral assay for the evaluation of compounds
against vaccinia virus, varicella zoster virus and human cytomegalovirus.
J. Virol. Methods 151, 66–73.
Gabrielli, L., Bonasoni, M.P., Santini, D., Piccirilli, G., Chiereghin, A., Petrisli, E.,
Dolcetti, R., Guerra, B., Piccioli, M., Lanari, M., Landini, M.P., Lazzarotto, T., 2012.
Congenital cytomegalovirus infection: patterns of fetal brain damage The
Ofﬁcial Publication of the European Society of Clinical Microbiology and
Infectious Diseases. Clin. Microbiol. Infect. 18, E419–E427.
Gross, O., Thomas, C.J., Guarda, G., Tschopp, J., 2011. The inﬂammasome: an
integrated view. Immunol. Rev. 243, 136–151.
Hamilton, S.T., Scott, G., Naing, Z., Iwasenko, J., Hall, B., Graf, N., Arbuckle, S., Craig,
M.E., Rawlinson, W.D., 2012. Human cytomegalovirus-induces cytokine changes
in the placenta with implications for adverse pregnancy outcomes. PLoS One 7,
e52899.
Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenﬁeld, C., Natanson-
Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T.I., Manaster, I., Gazit, R., Yutkin, V.,
Benharroch, D., Porgador, A., Keshet, E., Yagel, S., Mandelboim, O., 2006.
Decidual NK cells regulate key developmental processes at the human fetal–
maternal interface. Nat. Med. 12, 1065–1074.
Iwasaki, A., Medzhitov, R., 2013. Innate responses to viral infections. In: Cohen, J.I.,
Grifﬁn, D.E., Lamb, R.A., Martin, M.A., Racaniello, V.R., Roizman, B. (Eds.), Fields
Virology, sixth ed. Lippincott Williams and Wilkins, Philadelphia.
Juckem, L.K., Boehme, K.W., Feire, A.L., Compton, T., 2008. Differential initiation of
innate immune responses induced by human cytomegalovirus entry into
ﬁbroblast cells. J. Immunol. 180, 4965–4977.
Kobasa, D., Jones, S.M., Shinya, K., Kash, J.C., Copps, J., Ebihara, H., Hatta, Y., Kim, J.H.,
Halfmann, P., Hatta, M., Feldmann, F., Alimonti, J.B., Fernando, L., Li, Y., Katze, M.
G., Feldmann, H., Kawaoka, Y., 2007. Aberrant innate immune response in lethal
infection of macaques with the 1918 inﬂuenza virus. Nature 445, 319–323.
Kosmac, K., Bantug, G.R., Pugel, E.P., Cekinovic, D., Jonjic, S., Britt, W.J., 2013. Gluco-
corticoid treatment of MCMV infected newborn mice attenuates CNS inﬂammation
and limits deﬁcits in cerebellar development. PLoS Pathog. 9, e1003200.
Le Bouteiller, P., 2013. Human decidual NK cells: unique and tightly regulated
effector functions in healthy and pathogen-infected pregnancies. Front. Immu-
nol. 4, 404.
Markel, G., Wolf, D., Hanna, J., Gazit, R., Goldman-Wohl, D., Lavy, Y., Yagel, S.,
Mandelboim, O., 2002. Pivotal role of CEACAM1 protein in the inhibition of
activated decidual lymphocyte functions. J. Clin. Invest. 110, 943–953.
Mezger, M., Bonin, M., Kessler, T., Gebhardt, F., Einsele, H., Loefﬂer, J., 2009. Toll-like
receptor 3 has no critical role during early immune response of human
monocyte-derived dendritic cells after infection with the human cytomegalo-
virus strain TB40E. Viral Immunol. 22, 343–351.
Mocarski, E.S., Shenk, T., Pass, R.F., 2007. Cytomegaloviruses. In: Knipe, D.M., Howly,
P.M., Grifﬁn, D.E., Lamb, R.A., Martin, M.A. (Eds.), Fields Virology, ﬁfth ed.
Lippincott Williams and Wilkins, Philadelphia.
Monroe, K.M., Yang, Z., Johnson, J.R., Geng, X., Doitsh, G., Krogan, N.J., Greene, W.C.,
2014. IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively
infected with HIV. Science 343, 428–432.
Murphy, S.P., Tayade, C., Ashkar, A.A., Hatta, K., Zhang, J., Croy, B.A., 2009. Interferon
gamma in successful pregnancies. Biol. Reprod. 80, 848–859.
Nigro, G., Adler, S.P., La Torre, R., Best, A.M., Congenital Cytomegalovirus Collabor-
ating G., ., 2005. Passive immunization during pregnancy for congenital
cytomegalovirus infection. N. Engl. J. Med. 353, 1350–1362.
Pereira, L., Maidji, E., 2008. Cytomegalovirus infection in the human placenta:
maternal immunity and developmentally regulated receptors on trophoblasts
converge. Curr. Top. Microbiol. Immunol. 325, 383–395.
Pereira, L., Maidji, E., McDonagh, S., Tabata, T., 2005. Insights into viral transmission
at the uterine-placental interface. Trends Microbiol. 13, 164–174.
Pereira, L., Petitt, M., Fong, A., Tsuge, M., Tabata, T., Fang-Hoover, J., Maidji, E., Zydek,
M., Zhou, Y., Inoue, N., Loghavi, S., Pepkowitz, S., Kauvar, L.M., Ogunyemi, D.,
2014. Intrauterine growth restriction caused by underlying congenital cytome-
galovirus infection. J. Infect. Dis. 209, 1573–1584.
Potzsch, S., Spindler, N., Wiegers, A.K., Fisch, T., Rucker, P., Sticht, H., Grieb, N.,
Baroti, T., Weisel, F., Stamminger, T., Martin-Parras, L., Mach, M., Winkler, T.H.,
2011. B cell repertoire analysis identiﬁes new antigenic domains on glycopro-
tein B of human cytomegalovirus which are target of neutralizing antibodies.
PLoS Pathog. 7, e1002172.
Revello, M.G., Lazzarotto, T., Guerra, B., Spinillo, A., Ferrazzi, E., Kustermann, A.,
Guaschino, S., Vergani, P., Todros, T., Frusca, T., Arossa, A., Furione, M., Rognoni,
V., Rizzo, N., Gabrielli, L., Klersy, C., Gerna, G., Group, C.S., 2014. A randomized
trial of hyperimmune globulin to prevent congenital cytomegalovirus. N. Engl.
J. Med. 370, 1316–1326.
Ross, S.A., Boppana, S.B., 2005. Congenital cytomegalovirus infection: outcome and
diagnosis. Semin. Pediatr. Infect. Dis. 16, 44–49.
Rossini, G., Cerboni, C., Santoni, A., Landini, M.P., Landolfo, S., Gatti, D., Gribaudo, G.,
Varani, S., 2012. Interplay between human cytomegalovirus and intrinsic/
innate host responses: a complex bidirectional relationship. Mediators
Inﬂamm. 2012, 607276.
Sadler, A.J., Williams, B.R., 2008. Interferon-inducible antiviral effectors. Nat. Rev.
Immunol. 8, 559–568.
Schleiss, M.R., 2006. The role of the placenta in the pathogenesis of congenital
cytomegalovirus infection: is the beneﬁt of cytomegalovirus immune globulin
for the newborn mediated through improved placental health and function? An
Ofﬁcial Publication of the Infectious Diseases Society of America. Clin. Infect.
Dis. 43, 1001–1003.
Yiska Weisblum et al. / Virology 485 (2015) 289–296 295
Schleiss, M.R., 2013. Cytomegalovirus in the neonate: immune correlates of
infection and protection. Clin. Dev. Immunol. 2013, 501801.
Schleiss, M.R., Aronow, B.J., Handwerger, S., 2007. Cytomegalovirus infection of
human syncytiotrophoblast cells strongly interferes with expression of genes
involved in placental differentiation and tissue integrity. Pediatr. Res. 61,
565–571.
Scott, G.M., Chow, S.S., Craig, M.E., Pang, C.N., Hall, B., Wilkins, M.R., Jones, C.A.,
Lloyd, A.R., Rawlinson, W.D., 2012. Cytomegalovirus infection during pregnancy
with maternofetal transmission induces a proinﬂammatory cytokine bias in
placenta and amniotic ﬂuid. J. Infect. Dis. 205, 1305–1310.
Siewiera, J., El Costa, H., Tabiasco, J., Berrebi, A., Cartron, G., Le Bouteiller, P., Jabrane-
Ferrat, N., 2013. Human cytomegalovirus infection elicits new decidual natural
killer cell effector functions. PLoS Pathog. 9, e1003257.
Spaete, R.R., Mocarski, E.S., 1987. Insertion and deletion mutagenesis of the human
cytomegalovirus genome. Proc. Natl. Acad. Sci. U.S.A. 84, 7213–7217.
Stern-Ginossar, N., Elefant, N., Zimmermann, A., Wolf, D.G., Saleh, N., Biton, M.,
Horwitz, E., Prokocimer, Z., Prichard, M., Hahn, G., Goldman-Wohl, D., Green-
ﬁeld, C., Yagel, S., Hengel, H., Altuvia, Y., Margalit, H., Mandelboim, O., 2007.
Host immune system gene targeting by a viral miRNA. Science 317, 376–381.
Trundley, A., Gardner, L., Northﬁeld, J., Chang, C., Moffett, A., 2006. Methods for
isolation of cells from the human fetal–maternal interface. Methods Mol. Med.
122, 109–122.
Varani, S., Cederarv, M., Feld, S., Tammik, C., Frascaroli, G., Landini, M.P., Soderberg-
Naucler, C., 2007. Human cytomegalovirus differentially controls B cell and T
cell responses through effects on plasmacytoid dendritic cells. J. Immunol. 179,
7767–7776.
Weisblum, Y., Panet, A., Haimov-Kochman, R., Wolf, D.G., 2014. Models of vertical
cytomegalovirus (CMV) transmission and pathogenesis. Semin. Immunopathol.
36, 615–625.
Weisblum, Y., Panet, A., Zakay-Rones, Z., Haimov-Kochman, R., Goldman-Wohl, D.,
Ariel, I., Falk, H., Natanson-Yaron, S., Goldberg, M.D., Gilad, R., Lurain, N.S.,
Greenﬁeld, C., Yagel, S., Wolf, D.G., 2011. Modeling of human cytomegalovirus
maternal–fetal transmission in a novel decidual organ culture. J. Virol. 85,
13204–13213.
Wolf, D.G., Courcelle, C.T., Prichard, M.N., Mocarski, E.S., 2001. Distinct and separate
roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis
and encapsidation. Proc. Natl. Acad. Sci. U.S.A. 98, 1895–1900.
Wolf, D.G., Smith, I.L., Lee, D.J., Freeman, W.R., Flores-Aguilar, M., Spector, S.A., 1995.
Mutations in human cytomegalovirus UL97 gene confer clinical resistance to
ganciclovir and can be detected directly in patient plasma. J. Clin. Invest. 95,
257–263.
Yurochko, A.D., Huang, E.S., 1999. Human cytomegalovirus binding to human
monocytes induces immunoregulatory gene expression. J. Immunol. 162,
4806–4816.
Yiska Weisblum et al. / Virology 485 (2015) 289–296296
